USD 606.6 Billion
Oral Solid Dosage Pharmaceutical Formulation Market Size, Share, Growth Analysis, By Product type(Tablets (Conventional/Immediate Release, Modified Release, Chewable Tablets, Effervescent Tablets)), By Mechanism(Controlled-release, Immediate-release, and Delayed-release), By End-user(Large-size Companies, Medium- & Small-size Companies, Others (Startups & Generic Pharmaceutical Companies)), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2306 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|Tables:
95
|Figures:
71
Oral Solid Dosage Pharmaceutical Formulation Market Insights
Global Oral Solid Dosage Pharmaceutical Formulation Market size was valued at USD 606.6 Billion in 2022 and is poised to grow from USD 645.42 Billion in 2023 to USD 1060.17 Billion by 2031, at a CAGR of 6.4% during the forecast period (2024-2031).
The Global Oral Solid Dosage Pharmaceutical Formulation Market has been experiencing significant growth in recent years. Market dynamics are largely driven by factors such as increasing demand for oral medications, advancements in drug formulation technologies, and a growing aging population that requires long-term pharmaceutical treatment. Furthermore, the market has witnessed notable innovation in drug delivery methods, resulting in improved patient compliance and efficacy.
Additionally, regulatory agencies have been stringent in ensuring the quality and safety of oral solid dosage formulations, driving pharmaceutical companies to invest in research and development. Collaboration between pharmaceutical firms and contract manufacturing organizations has also played a pivotal role in expanding product portfolios.
Overall, the market for oral solid dosage pharmaceutical formulations is poised for continued expansion and evolution in response to the ever-evolving healthcare landscape.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Large-size Companies
Fastest Growth
Large-size Companies
Growth Rate
6.4% CAGR
Oral solid dosage pharmaceutical formulation market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Oral Solid Dosage Pharmaceutical Formulation Market Segmental Analysis
The global Oral solid dosage pharmaceutical formulation market is segmented on the basis of product type, mechanism, end-user and region. Based on product type, Tablets (Conventional/Immediate Release, Modified Release, Chewable Tablets, Effervescent Tablets), Capsules (Hard Gelatin Capsules, Soft Gelatin Capsules), Powders & Granules, Lozenges & Pastilles, and Gummies. Based on mechanism, the market is segmented as Controlled-release, Immediate-release, and Delayed-release. Based on end-user, it is segregated into Large-size Companies, Medium- & Small-size Companies, and Others (Startups & Generic Pharmaceutical Companies). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Product Type
Tablets remain the dominating product in the Global Oral Solid Dosage Pharmaceutical Formulation Market. Their widespread use is primarily attributed to ease of manufacturing, convenience in dosing, longer shelf life, and patient familiarity. Tablets are preferred for their stability and precise dosing, making them a preferred choice for a wide range of pharmaceutical formulations.
However, the category of "Others," which includes products like lozenges, gummies, and pastilles, is experiencing the fastest growth in the market. This growth can be attributed to increasing consumer preference for alternative dosage forms, especially among pediatric and geriatric populations. These novel formulations offer improved palatability and compliance, catering to diverse patient preferences and therapeutic needs. Additionally, the demand for these innovative dosage forms is bolstered by their potential for niche and specialty pharmaceutical applications.
Analysis by End-user
Large-size pharmaceutical groups dominate the Global Oral Solid Dosage Pharmaceutical Formulation Market. These mounted players advantage from sizable sources, robust studies and improvement talents, and a extensive distribution community, permitting them to effectively produce and marketplace oral solid dosage formulations. Their sturdy regulatory compliance and capability to adopt steeply-priced medical trials give them a competitive aspect in introducing new products and assembly stringent fine standards.
Moreover, the "Others" category, encompassing startups and accepted pharmaceutical agencies, is the fastest-developing phase within the market. This increase can be attributed to numerous factors, which include expanded call for for value-powerful regular pills, a push for innovation and niche formulations by means of startups, and a changing regulatory landscape that encourages competition. These agencies often leverage innovative methods, adapt quick to market desires, and revel in lower development charges, making them agile and attentive to emerging opportunities and market niches within the oral strong dosage pharmaceutical system quarter.
Oral solid dosage pharmaceutical formulation market by End-user
To get detailed analysis on other segments, Request For Free Sample Report
Oral Solid Dosage Pharmaceutical Formulation Market Regional Insights
North America is presently the dominating vicinity in the Global Oral Solid Dosage Pharmaceutical Formulation Market. This dominance can be attributed to factors along with a well-hooked up healthcare infrastructure, sturdy pharmaceutical enterprise, high healthcare spending, and a strong recognition on research and development. The presence of most important pharmaceutical corporations and favorable regulatory guidelines similarly make contributions to North America's leadership in this market.
However, the Asia Pacific region is experiencing the fastest growth inside the Oral Solid Dosage Pharmaceutical Formulation Market. This increase is pushed through elements like growing healthcare get entry to, growing disposable incomes, a huge affected person population, and increasing pharmaceutical manufacturing capabilities in countries like China and India. Additionally, a growing consciousness of oral stable dosage formulations as a favored medicinal drug approach and funding in pharmaceutical innovation are propelling the market's rapid growth in Asia Pacific.
Oral solid dosage pharmaceutical formulation market by Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Oral Solid Dosage Pharmaceutical Formulation Market Dynamics
Drivers
Technological Advancements in Drug Formulation
- Innovations which includes 3-D printing, nanotechnology, and stepped forward drug delivery systems are enhancing the performance and effectiveness of oral strong dosage medicinal drugs. These advancements no longer only improve affected person compliance but additionally enable pharmaceutical corporations to broaden novel formulations, using market boom.
Restraints
Stringent Regulatory Approval Processes
- The pharmaceutical industry is challenge to rigorous scrutiny by using regulatory companies worldwide to make certain drug safety and efficacy. These lengthy and complicated approval processes can cause delays in product launches, improved improvement charges, and prevent marketplace access for brand new players. Meeting these stringent regulatory requirements remains a significant challenge in the industry.
Request Free Customization of this report to help us to meet your business objectives.
Oral Solid Dosage Pharmaceutical Formulation Market Competitive Landscape
The competitive landscape in the Global Oral Solid Dosage Pharmaceutical Formulation Market is characterized by intense rivalry among pharmaceutical companies striving to capture a significant market share.
Players in this landscape are continually engaged in research and development efforts to create innovative formulations and enhance existing product portfolios. Strategic collaborations and partnerships are common, facilitating the exchange of knowledge and resources.
Additionally, companies are focusing on maintaining high-quality standards and regulatory compliance to ensure the safety and efficacy of their products. Market consolidation through mergers and acquisitions is also a notable trend, further shaping the competitive dynamics in this evolving sector.
Top Player’s Company Profiles
- Catalent, Inc. (US)
- Lonza Group (UK)
- Piramal Pharma Solutions (India)
- Aenova (Germany)
- Jubilant (India)
- Boehringer Ingelheim (Germany)
- AbbVie Contract Manufacturing (US)
- Patheon (US)
- Recipharm (Sweden)
- Next Pharma AB (Sweden)
- Siegfried AG (Switzerland)
- Corden Pharma (Switzerland)
- Famar (Greece)
- Alkermes (Ireland)
- Hetero Labs Limited (India)
Recent Developments
-
April 2023: Eli Lilly and Company announced the launch of its new bilayer tablet formulation of Trulicity (dulaglutide) for the treatment of type 2 diabetes.
-
May 2023: AstraZeneca plc announced the launch of its new once-daily oral tablet formulation of Farxiga (dapagliflozin) for the treatment of type 2 diabetes and heart failure with preserved ejection fraction.
- June 2023: Novartis AG announced the launch of its new extended-release tablet formulation of Vytorin (ezetimibe and simvastatin) for the treatment of high cholesterol.
Oral Solid Dosage Pharmaceutical Formulation Key Market Trends
- Personalized Medicine and Tailored Formulations: Advances in genetic profiling and biomarker identification have allowed pharmaceutical companies to develop medications customized to individual patient needs. This trend not only enhances treatment outcomes but also promotes patient adherence, leading to the development of niche markets for precision oral solid dosage formulations. As the healthcare industry continues to prioritize patient-centric approaches, the demand for personalized oral solid dosage medications is expected to rise significantly.
Oral Solid Dosage Pharmaceutical Formulation Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to global oral solid dosage pharmaceutical formulation market analysis, the market has been on a robust growth trajectory, driven by several key factors. The market benefits from a rising global population and an aging demographic, which necessitates a consistent supply of oral medications. Furthermore, continuous technological advancements in drug formulation, such as 3D printing and nanotechnology, have improved drug delivery and efficacy, contributing to market expansion.
However, challenges persist, primarily concerning stringent regulatory approval processes and the growing demand for personalized medicine. Meeting these regulatory requirements remains a formidable task for pharmaceutical companies, often resulting in delays and increased development costs. The emergence of tailored formulations to cater to individual patient needs is reshaping the market, presenting both opportunities and challenges.
Looking ahead, the market is poised for continued growth, with the Asia Pacific region expected to be a key driver due to its expanding pharmaceutical manufacturing capabilities and increasing healthcare access. The trend towards personalized medicine is likely to gain further momentum, necessitating innovative approaches to formulation development. Strategic collaborations and mergers and acquisitions are expected to shape the competitive landscape.
In conclusion, while regulatory hurdles and personalized medicine trends pose challenges, the Global Oral Solid Dosage Pharmaceutical Formulation Market is set to witness sustained growth and innovation in the coming years, with a focus on improving drug delivery, patient compliance, and healthcare outcomes.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 606.6 Billion |
| Market size value in 2031 | USD 1060.17 Billion |
| Growth Rate | 6.4% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Oral Solid Dosage Pharmaceutical Formulation Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Oral Solid Dosage Pharmaceutical Formulation Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Oral Solid Dosage Pharmaceutical Formulation Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Oral Solid Dosage Pharmaceutical Formulation Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Oral Solid Dosage Pharmaceutical Formulation Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Oral Solid Dosage Pharmaceutical Formulation Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
